Last week I mentioned two new myeloma drugs on the horizon. Anyone know anything about these drugs? I know both are being tested in clinical trials. I know HuLuc63 is hoped to use the bodies monoclonal antibodies to destroy myeloma cells. I know GRN163L is a telomerase inhibitor, which hopefully will block an enzyme found to be active in myeloma cells that, according to CancerCare’s recently published booklet, Advances in the Treatment of Multiple Myeloma, allows cancer cells to resist chemotherapy. Please e-mail me or post a comment if you know anything about either of these experimental drugs. Thank you!
Feel good and keep smiling! Pat